Neurobiological and anthropological aspects of compulsions and rituals

Pharmacopsychiatry

Volumn 32, Issue 6, 1999, Pages 223-229

  Heinz, A ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; COMPULSION; CONFLICT; CULTURAL ANTHROPOLOGY; DOPAMINERGIC SYSTEM; GILLES DE LA TOURETTE SYNDROME; HUMAN; MEDIAN RAPHE NUCLEUS; NEUROBIOLOGY; NEUROPATHOLOGY; OBSESSION; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; STEREOTYPY; TIC;

ANTHROPOLOGY; COMPULSIVE BEHAVIOR; HUMANS; NEUROBIOLOGY; OBSESSIVE-COMPULSIVE DISORDER;

EID: 0032708501     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-7959     Document Type: Article

References (64)

1. Alexander GE, De Long MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann. Rev. Neurosci. 1986; 9: 357-381
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. American Psychiatric Association, Washington DC 1995
3. Asberg M, Thoren L, Bertilsson L: Clomipramine treatment of obsessive-compulsive disorder: Biochemical and clinical aspects. Psychopharmaco] Bull 1982; 18: 13-21
4. Baumgarten HG, Crozdanovic Z: Anatomy of central serotonergic projection system. In: Baumgarten HG, Göthert M: Handbook of Experimental Pharmacology. Serotonergic Neurons and 5-HT Receptors in the CNS. Springer, Berlin, Heidelberg 1997; 129: 41-89
5. Baxter LR Jr, Phleps ME, Mazziotta JC, Guze BH, Schwarzt JM, Selin CE: Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression. Arch. Gen. Psychiat. 1987; 44: 211-218
6. Baxter LR Jr, Schwartz JM, Bergman KM, Szuba MP, Guze BH, Mazziotta JC, Akazraju A, Selin CE, Ferng HK, Munford P, Phleps ME: Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch. Gen. Psychiat. 1992; 49: 681-689
7. Böll H: Nicht nur zur weihnachtszeit. In: Dr. Murkes Gesammeltes Schweigen and Andere Satiren. Kiepenheuer and Witsch, Köln 1977: 54-106
8. Brodie MS, Bunney EB: Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vitro. J. Neurophys. 1996; 76: 2077-2082
9. Brooks A, Pigott TA, Hill JL, Canter S, Grady TA, L'Heureux F, Murphy DL: Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results. Psychiat. Res. 1998; 79: 11-20
10. Cohen DJ, Shaywitz B, Caparulo B, Young JG, Bowers MB: Chronic, multiple tics of Gilles de la Tourette disease. CSFacid monoamine metabolites after probenecid administration. Arch. Gen. Psychiat. 1978; 35: 245-250
11. Cummings JL: Frontal-subcortical circuits and human behavior. Arch. Neurol. 1993; 50: 873-880
12. Cummings JL, Frankel M: Gilles de la Tourette Syndrome and the neurological basis of obsessions and compulsions. Biol. Psychiat. 1985; 20: 1117-1126
13. Devinsky O: Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement. Arch. Neural. 1983; 40: 508-514
14. Dewey SL, Smith CS, Logan J, Alexoff D, Ding YS, King P, Pappas N, Brodie JD, Ashby CR: Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J. Neurosci. 1995; 15: 821-829
15. Duerr HP: Sedna Oder die Liebe zum Leben. Suhrkamp, Frankfurt/M. 1984
16. Evans-Pritchard EE: Theories of Primitive Religion. Oxford University Press, Oxford 1981
17. Fähndrich E (ed.): Arbeitsgemeinschaft für Methodik and Dokumentation in der Psychiatrie. Das AMDP-System. Manual zur Dokumentation Psychischer Befunde. Springer, Berlin, Heidelberg, New York 1981
18. Farde L, Halldin C, Mueller L, Suhara T, Karlsson P, Hall H: PET study of [C-11][β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 1994; 16: 93-103
19. Fisher RE, Morris ED, Alpert NM, Fischman AJ: In vivo imaging of neuromodulatory synaptic transmission using PET: A review of relevant neurophysiology. Human Brain Map. 1995; 3: 24-34
20. Freddman M, Black S, Ebert P, Binns M: Orbitofrontal function, object alteration and perseveration. Cereb. Cortex 1998; 8: 18-27
21. Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS: Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch. Gen. Psychiat. 1990; 47: 577-585
22. Grace AA: Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neurosci. 1991; 41: 1-24
23. Gross-Iseroff R, Sasson Y, Voet H, Hendler T, Lura-Haimovici K, Kandel-Sussman H, Zohar J: Alteration learning in obsessive-compulsive disorder. Biol. Psychiat. 1996; 39: 733-738
24. Hall LM, Anderson GM, Cohen DJ: Acute and chronic effects of fluoxetine and haloperidol on mouse brain serotonin and norepinephrine turnover. Life Sci. 1995; 57: 791-801
25. Heinz A: Savage thought and thoughtful savages. On the context of the evaluation of logical thought by Levy-Bruhl and EvansPritchard. Anthropos 1997; 92: 165-173
26. Heinz A: Colonial perspectives in the construction of the psychotic patient as primitive man. Critique Anthropol. 1998; 18: 421-444
27. Heinz A, Knable MB, Wolf SS, Jones DW, Gorey J, Hyde TS, Weinberger DR: Tourette's syndrome: Serotonin transporters predict severity of vocal tics. Neurology 1998a; 51: 1069-1074
28. Heinz A, Higley JD, Jones DW, Gorey JG, Sounders R, Zajicek K, Suomi SS, Knable MB, Weinberger DR, Linnoila M: In vivo observation of an association between serotonin transporters and sensitivity to alcohol intoxication. Am. J. Psychiat. 1998b; 155: 1023-1028
29. Heinz A, Saunders RC, Kolachana BS, Jones DW, Gorey JG, Bachevalier J, Weinberger DR: Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage. Synapse 1999; 39: 71-79
30. Hyde TM, Weinberger DR: Tourette's Syndrome. A model neuropsychiatric disorder. J.A.M.A. 1995; 273: 498-501
31. Inset TR, Mueller EA, Alterman I, Linnoila M, Murphy DL: Obsessive-compulsive disorder and serotonin: Is there a connection? Biol. Psychiat. 1985; 20: 1174-1185
32. Jackson JH: Die Croon-Vorlesungen Über Aufbau and Abbau des Nervensystems. Springer, Berlin 1927
33. Kreiss DS, Lucki I: Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 1995; 274: 866-876
34. Lajonchere C, Nortz M, Finger S: Gilles de la Tourette and the discovery of Tourette Syndrome. Includes a translation of his 1884 article. Arch. Neurol. 1996; 53: 567-574
35. Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, Al-Tikriti MS, Sybirska MH, Zimmermann RC, Wiesniewski C, Neumeyer JL, Milius RA, Wang S, Smith EO, Roth RH, Charney DS, Hojjer PB, Innis RB: SPECT imaging of dopamine and serotonin transporters with [123-I]β-CIT: Pharmacological characterization of brain uptake in non-human primates. Synapse 1993; 13: 295-309
36. Laruelle M, Wallace E, Seibyl JP, Baldwin RM, Zea-Ponce Y, Zoghbi SS, Neumeyer JL, Charney DS, Hoffer PB, Innis RB: Graphical, kinetic, and equilibrium analyses of in vivo [123-1]β-CIT binding to dopamine transporters in healthy human subjects. J. Cerebr. Blood Flow Metab. 1994; 14: 982-994
37. Leach ER: Ritualization in man in relation to conceptual and social development. In: Huxley J (ed.): Philosophical Transaction of the Royal Society of London. Biological Sciences. Royal Society, London, Series B 1966; 251
38. Lehmann A, Myers J: Magic, Witchcraft and Religion: An Anthropological Study of the Supernatural. Mayfield Publishing, Mountain View CA 1989; 251
39. Lundmark J, Walinder J, Ailing C, Manniche PM, Dalgaard L: The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients. Europ. Neuropsychopharmacol. 1994; 4: 1-6
40. Malinowski B: Baloma - Die geister der toten auf den trobriand-inseln. In: Magie, Wissenschaft und Religion. Fischer, Frankfurt/M. 1973: 172-173
41. Marek GJ, McDougle CJ, Price LH, Seiden LS: A comparison of trazodone and fluoxetine: Implications for a serotonergic mechanism of antidepressant action. Psychopharmacol. Berlin 1992; 109: 2-11
42. McCormick DA: Neurotransmitter actions in the thalamus and cerebral cortex. J. Clin. Neurophys. 1992; 9: 212-223
43. McDougle CJ, Goodman WK, Price LH: Dopamine antagonists in tic-related and psychotic spectrum obsessive-compulsive disorder. J. Clin. Psychiat. 1994; 55: 24-31
44. McGuire PK, Bench CJ, Frith CD, Marks IM, Franckowiak RS, Dolan RJ: Functional anatomy of obsessive-compulsive phenomena. Br. J. Psychiat. 1994; 164: 459-468
45. McLean P: A Triune Concept of Brain and Behavior. University of Toronto Press, Toronto 1973
46. Muck-Seler D, Jevric-Causevic A, Diksic M: Influence of fluoxetine on regional serotonin synthesis in the rat brain. J. Neurochem. 1996; 67: 2434-2442
47. Mumenthaler M, Mattle H: Neurologie. Syndrome des Frontallappens. Stuttgart, New York, Thieme 1997: 389-392
48. Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, Bellodi L, SmeraldiE, Fazio F: [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br. J. Psychiat. 1995; 166: 244-250
49. Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G, Pozzera A, Deecke L, Podreka I, Brücke T: β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J. Neural Transm. 1995; 100: 247-256
50. Rapoport JL: The biology of obsessions and compulsions. Scientific Am. 1989; 3: 83-89
51. Riederer P, Sofic E, Rausch D, Hebenstreit G, Bruinvels J: Pathobiochemistry of Parkinson's disease: A "short note" review. In: Przuntek H, Riederer P (eds): Early Diagnosis and Preventive Therapy in Parkinson's Disease. Springer, Wien, New York 1989: 139-150
52. Sandyk R: A case of Tourette's syndrome with midbrain involvement. Intern. J. Neurosci. 1988; 43: 171-175
53. Schwartz JM, Stoessel PW, Baxter LR, Martin KM, Phleps ME: Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch. Gen. Psychiat. 1996; 53: 109-113
54. Singer HS, Butler IJ, Tune LE, Seifert WE, Coyle JT: Dopamine dysfunction in Tourette syndrome. Ann. Neurol. 1982; 12: 361-366
55. Storozhuk VM, Sachenko W, Kruchenko JA: Dependence of sensorimotor cortex neuron activity on noradrenergic and serotonergic transmission in unspecific thalamic nuclei. Neurosci. 1995; 68: 315-322
56. Swedo SE, Pietrini P, Leonard HL, Shapiro MB, Rettow DC, Goldberger EL, Rapoport SI, Grady CL: Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch. Gen. Psychiat. 1992; 49: 690-694
57. Swedo SE, Leonard HL: Childhood movement disorders and obsessive compulsive disorder. J. Clin. Psychiat. 1994; 55 (Suppl): 32-37
58. Thoren P, Asberg M, Bertilsson B, Mellstrom B, Sjoqvist F, Traskman L: Clomipramine treatment of obsessive-compulsive disorder: II. Biochemical aspects. Arch. Gen. Psychiat. 1980; 37: 1289-1294
59. Trent F, Tepper JM: Dorsal raphe stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo. Exp. Brain Res. 1991; 84: 620-630
60. Turner V: The Anthropology of Performance. PAJ Publications, New York 1988
61. Wolf S, Jones DW, Knable MB, Gorey JG, Lee KS, Hyde TM, Coppola R, Weinberger DR: Tourette Syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 1996; 273: 1225-1227
62. World Health Organization: Tenth revision of the International Classification of Diseases, Chapter V (F). Mental and Behavioral Disorders. Huber, Göttingen 1991
63. Zohar J, Insel TR: Obsessive-compulsive disorder: Psychobiological approaches to diagnosis, treatment and pathophysiology. Biol. Psychiat. 1987; 22: 667-687
64. Zohar J, Mueller EA, Insel TR, Rachel-Kadouch RC, Murphy DL: Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Arch. Gen. Psychiat. 1987; 44: 946-951